KOPS - Das Institutionelle Repositorium der Universität Konstanz

Poly(ADP-ribose) glycohydrolase as a target for neuroprotective intervention : assessment of currently available pharmacological tools

Poly(ADP-ribose) glycohydrolase as a target for neuroprotective intervention : assessment of currently available pharmacological tools

Zitieren

Dateien zu dieser Ressource

Prüfsumme: MD5:7f749774ebabafbe8cb8646c1a247595

FALSIG, Jeppe, Søren HOFMAN CHRISTIANSEN, Sascha FEUERHAHN, Alexander BÜRKLE, Shiao LI OEI, Claudia KEIL, Marcel LEIST, 2004. Poly(ADP-ribose) glycohydrolase as a target for neuroprotective intervention : assessment of currently available pharmacological tools. In: European Journal of Pharmacology. 497(1), pp. 7-16. ISSN 0014-2999. Available under: doi: 10.1016/j.ejphar.2004.06.042

@article{Falsig2004PolyA-8379, title={Poly(ADP-ribose) glycohydrolase as a target for neuroprotective intervention : assessment of currently available pharmacological tools}, year={2004}, doi={10.1016/j.ejphar.2004.06.042}, number={1}, volume={497}, issn={0014-2999}, journal={European Journal of Pharmacology}, pages={7--16}, author={Falsig, Jeppe and Hofman Christiansen, Søren and Feuerhahn, Sascha and Bürkle, Alexander and Li Oei, Shiao and Keil, Claudia and Leist, Marcel} }

<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/rdf/resource/123456789/8379"> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/28"/> <dc:language>eng</dc:language> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-24T17:43:09Z</dc:date> <dc:creator>Li Oei, Shiao</dc:creator> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-24T17:43:09Z</dcterms:available> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:creator>Falsig, Jeppe</dc:creator> <dc:contributor>Bürkle, Alexander</dc:contributor> <dc:rights>deposit-license</dc:rights> <dc:contributor>Li Oei, Shiao</dc:contributor> <dcterms:title>Poly(ADP-ribose) glycohydrolase as a target for neuroprotective intervention : assessment of currently available pharmacological tools</dcterms:title> <dc:contributor>Falsig, Jeppe</dc:contributor> <dc:creator>Feuerhahn, Sascha</dc:creator> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/8379/1/Falsig_et_al_EJP_2004.pdf"/> <dc:creator>Leist, Marcel</dc:creator> <dcterms:abstract xml:lang="eng">Poly(ADP-ribose) glycohydrolase (PARG) is being considered as a therapeutic target for the prevention of neurodegeneration. Here, we assessed the pharmacological tools available for target validation. The tannic acid derivative gallotannin inhibited PARG in a cell-free assay but had no detectable effect on PARG function in intact cells. Its cytoprotective actions were associated rather with the radical-scavenging potential of the compound. In astrocytes exposed to high concentrations of the nonoxidative DNA-damaging agent N-methyl-N′-nitro-N-nitrosoguanidine (MNNG), Poly(ADP-ribose) polymerase (PARP) inhibitors were fully protective, while gallotannin enhanced the damage. The compound N-bis-(3-phenyl-propyl)9-oxo-fluorene-2,7-diamide (GPI 16552), considered a potentially specific PARG inhibitor, had no effect in the different astrocyte death models compared with PARP inhibitors. In an in vitro PARG activity assay, the maximal inhibition that could be achieved with GPI 16552 was only 40% at a drug concentration of 80 μM. We conclude that neither GPI 16552 nor gallotannin are suitable for the evaluation of PARG in cellular death models, and that previous conclusions drawn from the use of these compounds should be interpreted with caution.</dcterms:abstract> <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/8379"/> <dcterms:bibliographicCitation>First publ. in: European Journal of Pharmacology 497 (2004), 1, pp. 7-16</dcterms:bibliographicCitation> <dc:contributor>Leist, Marcel</dc:contributor> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/28"/> <dc:creator>Hofman Christiansen, Søren</dc:creator> <dc:contributor>Keil, Claudia</dc:contributor> <dc:format>application/pdf</dc:format> <dc:creator>Bürkle, Alexander</dc:creator> <foaf:homepage rdf:resource="http://localhost:8080/jspui"/> <dc:contributor>Feuerhahn, Sascha</dc:contributor> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/8379/1/Falsig_et_al_EJP_2004.pdf"/> <dc:contributor>Hofman Christiansen, Søren</dc:contributor> <dc:creator>Keil, Claudia</dc:creator> <dcterms:rights rdf:resource="http://nbn-resolving.org/urn:nbn:de:bsz:352-20140905103416863-3868037-7"/> <dcterms:issued>2004</dcterms:issued> </rdf:Description> </rdf:RDF>

Dateiabrufe seit 01.10.2014 (Informationen über die Zugriffsstatistik)

Falsig_et_al_EJP_2004.pdf 273

Das Dokument erscheint in:

KOPS Suche


Stöbern

Mein Benutzerkonto